The pharmacogenetics of antiplatelet agents: towards personalized therapy?
about
Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysisIndividualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.Single nucleotide polymorphism network: a combinatorial paradigm for risk prediction.Influence of Cyp2c19*2 Gene Variant on Therapeutic Response During Clopidogrel Treatment in Patients with Carotid Artery Stenosis.The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day.Identifying determinants of variability to tailor aspirin therapy.Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.Pharmacogenomics of oral antiplatelet drugs.Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome.Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.Evaluation of pharmacokinetic, pharmacodynamic, efficacy, and safety data of low-dose ticagrelor versus standard dose in East Asians: a systematic review.Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept study.Emerging Role of Precision Medicine in Cardiovascular Disease.
P2860
Q27010236-C1DE3A0D-828A-41A6-AD6C-7A2478590FA8Q30373969-3BB75659-4C61-4625-8EE8-E6846711751CQ34989717-32E94CAE-0C34-4DB4-BB7E-BDF45D95C844Q37694929-702255BB-CC2F-420F-B8A6-84AB9F188D24Q38053481-74735A68-C5DE-4CAC-8797-8529270EE41CQ38087384-CF5D0AD8-BD99-4AE8-A158-A7DD0A26E27EQ38148597-62426410-6978-4C86-A121-EA6154F1E9BAQ38195628-2F6FD40B-22C9-4D23-80A6-E52385B871E6Q38243032-33834516-DF52-48CE-879E-E52CB243252BQ38377522-C13D4708-D574-4184-9E78-9B415D1ABCAAQ38974781-AB56B2C9-6353-45D9-A2F7-9723C049272AQ49540317-1ED80B95-E278-4134-956B-900206DE85C2Q50622756-751B2274-4BD1-4702-ABBC-E6AFA4AF6C72Q53748314-7A1AFF65-26D3-4079-AC68-1FF86AE59DE9
P2860
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
@en
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
@nl
type
label
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
@en
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
@nl
prefLabel
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
@en
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
@nl
P2860
P1476
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
@en
P2093
Richard C Becker
Tariq Ahmad
P2860
P304
P356
10.1038/NRCARDIO.2011.111
P407
P50
P577
2011-08-09T00:00:00Z